Our Investigators
PRCCI Leadership

Dr. Amarilys Silva, Pharm. D
Doctor of Pharmacy (Pharm.D.) with diverse experience working in Healthcare and global exposure in the Pharmaceutical Industry in the areas of Research, Medical Affairs, Global Product Safety/Pharmacovigilance, Regulatory Affairs. Dr. Silva holds a Bachelor’s degree in Pharmaceutical Sciences from the University of Puerto Rico, School of Pharmacy, and a Doctor of Pharmacy degree from the University of Florida, Gainesville. Proficient in multiple Therapeutic Areas, Academic partnerships, Compliance, GxPs, Auditing (FDA, EMEA, etc.) along with strong managerial and clinical experience.
Dr. Silva is recognized as a leader in Clinical Research by the Puerto Rico medical community, Academia, government institutions, and pharmaceutical industry. She is also recognized as a partner of excellence and has developed relationships of mutual trust and respect with many internal and external stakeholders in US and Puerto Rico. Dr. Silva is passionate about diversity and inclusion. She is focused on innovation to help improve patient outcomes.
Amarilys Silva-Boschetti, PharmD
Executive Director
PRCCI Investigators
PRCCI is proud to collaborate with a network of exceptional investigators. Learn more about their research areas and how they contribute to our mission of advancing healthcare.

David E. Barreto Bermonty, MD
David E. Barreto Bermonty, MD
Internal Medicine, Pulmonary and Critical Care Fellow
Sub-Investigator in Uncontrolled Asthma and Bronchiectasis Studies

Maribel Campos Rivera, MD MSc MBA-HCM FAAP Dipl ABOM and ACLM
Maribel Campos Rivera, MD MSc MBA-HCM FAAP Dipl ABOM and ACLM
Neonatologist, Pediatrician, Lifestyle Medicine
Principal Investigator in studies on obesity caused by genetic variants, pediatric migraine, and adult obesity.

Wihelma Echevarría Cortés, MD
Wihelma Echevarría Cortés, MD
Pediatric Gastroenterology

Ricardo Fernández, MD
Since 2012, he has served as the director of the training program at San Juan Hospital, a role that inspired him to fully immerse himself in the field of research. He has participated in more than 30 research studies and contributed to over 30 publications, many of them in peer-reviewed journals both locally and internationally. This experience has been highly rewarding, as he has witnessed the impact of these efforts in the development of medications and protocols that enhance patient care and management.
Ricardo Fernández, MD
Pulmonology and Critical Care
Principal Investigator in a clinical study for the treatment of uncontrolled asthma and bronchiectasis.

Nicolas Rosario-Matos, MD, MSc, MTh
Throughout his career, Dr. Rosario has collaborated on numerous clinical trials funded by the NIH, pharmaceutical industry and other research networks, and he has co-authored multiple publications on pediatric health outcomes. His work has contributed to understanding how prenatal exposure to events like Hurricane Maria affects infant microbiomes. Dr. Rosario is committed to improving health outcomes, particularly in populations impacted by social and environmental challenges.
Nicolas Rosario-Matos, MD, MSc, MTh
HIV, Vaccines, Rheumatology, Endocrinology, Dermatology, Neurology & Gastroenterology